Clinical Trials Browser

Phase 2/3 × Terminated × Nivolumab × Clear all

NCT04695977 2025-09-05

CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma

Phase 2/3 Terminated

20 enrolled 18 charts

Melanoma

NCT04901988 2025-02-27

DETECTION

Phase 2/3 Terminated

Melanoma